ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 244 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $737,092 | +88.2% | 20,670 | +34.1% | 0.81% | +69.0% |
| Q1 2023 | $391,617 | -64.0% | 15,418 | -42.6% | 0.48% | -54.9% |
| Q4 2022 | $1,089,158 | +60.2% | 26,853 | +20.8% | 1.06% | +57.2% |
| Q3 2022 | $680,000 | -0.7% | 22,235 | +14.4% | 0.68% | +7.0% |
| Q2 2022 | $685,000 | -6.5% | 19,444 | +22.0% | 0.63% | +18.8% |
| Q1 2022 | $733,000 | +184.1% | 15,933 | +309.3% | 0.53% | +199.4% |
| Q4 2021 | $258,000 | -96.2% | 3,893 | -95.6% | 0.18% | -89.3% |
| Q4 2020 | $6,766,000 | -11.8% | 88,183 | -50.5% | 1.66% | -27.0% |
| Q3 2020 | $7,673,000 | -0.3% | 178,183 | 0.0% | 2.27% | -11.5% |
| Q2 2020 | $7,696,000 | +216.4% | 178,183 | +110.8% | 2.57% | +151.7% |
| Q1 2020 | $2,432,000 | – | 84,537 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |